A Phase III Registration Study to Evaluate Camcevi in China
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Registrational; Therapeutic Use
- 01 Dec 2020 New trial record
Latest Information Update: 01 Dec 2020